XML 116 R39.htm IDEA: XBRL DOCUMENT v3.26.1

List of subsidiaries

12 Months Ended

Dec. 31, 2025

Disclosure of subsidiaries [abstract]

List of subsidiaries

List of subsidiaries

The following list contains the material subsidiaries of the Group at December 31, 2025 and 2024 are as follows:

Name of subsidiaries						Place of incorporation/ operation						Issued and fully paid share capital						Proportion of nominal value of issue capital held by the Company																								Principal activities
																		2025												2024
																		Directly						Indirectly						Directly						Indirectly
																		%						%						%						%
Prenetics Limited						Hong Kong						HK$415,276,716						—						100						—						100						Genetic and diagnostic health testing
Europa Partners Holdings, LLC (note 33)						The United States						GBP11.00						—						100						—						100						Provision of fulfillment and distribution services of sports nutrition products
IM8 Group Holding Company						Cayman Islands						$1						100						—						100						—						Sales of consumer health products
IM8 (US) LLC						The United States						n/a						100						—						100						—						Sales of consumer health products
IM8 Limited						Hong Kong						HK$1						100						—						100						—						Sales of consumer health products
ACT Genomics Holdings Company Limited						Cayman Islands						$16,713						—						—						73.27						—						Precise cancer genetic testing services
ACT Genomics Co., Ltd.						Taiwan						TWD455,080,000						—						—						—						73.21						Precise cancer genetic testing - services
ACT Genomics (Hong Kong) Limited						Hong Kong						HK$775,000						—						—						—						73.27						Precise cancer genetic testing - services
Sanomics Limited						Hong Kong						HK$500,000						—						—						—						73.27						Precise cancer genetic testing - services
MC Diagnostics Limited						United Kingdom						GBP1,164						—						—						—						73.27						Sales of medical diagnostics products

X

- References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of subsidiaries. [Refer: Total for all subsidiaries [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2025-01-01
-Paragraph 17
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard
-URIDate 2025-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2025-01-01
-Paragraph 16
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard
-URIDate 2025-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 75
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard
-URIDate 2025-03-27

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2025-01-01
-Paragraph B4
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B
-URIDate 2025-03-27

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 75
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration